C
CIN Terminal
Cannabis Investor News
A CanIDeal, Inc. Company
J
Live
Loading market data...
Expand
Symbol Name Exchange Last Change Volume Watch
Home › Markets › Loading…
GLASF US MSO

Glass House Brands

OTCMKTS · GLASF

California-focused cultivator and retailer operating one of the largest greenhouses in North America.

$10.79
—
Live Price
Price History 5 Years

Analyst Coverage

Cannabis Investor News in-house rating · cin-analyst-v1.0

Neutral Conviction 2/5
47/100 composite
Fundamentals57
Regulatory49
Market40
Editorial30
Composite · trailing 12 months

Glass House Brands carries a Neutral rating, with a composite score just below 47 and conviction at two out of five. Fundamentals provide the strongest contribution in the upper 50s, led by the market-cap tier around 80, cash-runway scoring near 69, and gross-margin scoring in the low 60s. Regulatory factors rank second at roughly 49, reflecting a balanced jurisdiction posture and a strong enforcement subscore, offset by weak filing cadence. Market support remains limited near 40 because no current quote was available from institutional pricing feeds, while the editorial pillar sits at 30 amid no qualifying CIN newsroom coverage. The combined profile supports balance rather than directional upside, particularly under a stretched financial condition.

Licensed fundamentals data show year-over-year revenue contraction of almost 10%, limiting the benefit of a gross margin approaching 38%. Operating margin remained deeply negative at roughly 35% below breakeven, while the net loss exceeded $36 million and EBITDA was negative by nearly $11 million. Those losses reinforce the stretched designation despite a cash-burn ratio near 1%. Equity value slightly above $1 billion supports the strongest fundamentals subscore, but valuation scale does not offset current earnings pressure. Primary regulatory filings show no events during the latest 90-day period and two over the past 180 days, with the latest filing dated mid-June 2026. The absence of enforcement hits supports the regulatory pillar’s strongest component, although the cadence subscore in the mid-20s constrains the overall regulatory contribution.

The clearest forward catalyst rests within fundamentals, the highest-rated pillar. A return to positive revenue growth would directly improve the weakest operating trend and create a stronger base for gross-margin conversion. Sustained margin discipline could then narrow both the operating deficit and EBITDA loss, allowing the relatively favorable market-cap, gross-margin, and cash-runway subscores to carry greater weight without contradicting the stretched financial condition. Better filing cadence could reinforce visibility, but regulatory and editorial inputs remain secondary to operating execution. The single most important signal to watch is a reported return to year-over-year revenue growth accompanied by a narrower operating loss.

Scored: 2026-10-14Valid through: 2026-11-28Weights: Fundamentals 35% · Regulatory 25% · Market 25% · Editorial 15%
Loading CIN Rating…
Fundamentals SEC & Market Data
Loading fundamentals…
Analyst Consensus
Loading analyst data…
Valuation Multiples
Loading…
Price Statistics
Loading…
Financing Activity
Loading financing data…
Insider Transactions
Loading insider data…
Regulatory Filings
Loading regulator disclosures…
Peer Comparison
Loading peer data…
Institutional DetailIR, corporate, and filing data from CIN enrichment
Corporate DetailsCompany profile
Headquarters
3645 LONG BEACH BLVD, LONG BEACH, CA, 90807
Phone
562-264-5078
SEC CIK
1848731
Website
Company website
Fundamentals & FinancialsRefreshed nightly from licensed fundamentals data
Market cap
$1.01B
Enterprise value
$1.12B
Price to book
11.86
Price to sales
5.67
EV / EBITDA
150.03
Revenue (TTM)
$177.7M
Gross profit (TTM)
$66.9M
EBITDA
$-10.9M
Operating margin
-35.4%
Profit margin
-20.7%
Rev growth YoY
-9.6%
Return on equity
-20.4%
Return on assets
-5.3%
EPS (TTM)
$-0.60
EPS est. current year
$-0.12
Wall St. target price
$16.00
Shares outstanding
78.9M
Insider ownership
8.4%
Institutional ownership
7.2%
Beta
0.51
Full-time employees
357
GICS sector
Health Care
GICS industry
Pharmaceuticals
Filings & DisclosuresPrimary sources
Annual report
Latest 10-K
Filing portal
SEC EDGAR
See something incorrect or missing?

Help us keep coverage accurate. Submit an update for CIN editorial review.

Submit an update
Complimentary Research
Would you like a deeper analysis on this company?

Request a complimentary, fully customized institutional-quality research report — tailored to your investment thesis.

Request Complimentary Report

Bullish and Bearish Analyst Opinions for Glass House Brands (GLASF)

Cannabis Investor News aggregates analyst coverage, price targets, insider transactions, SEC filings, and financing activity for Glass House Brands (GLASF), a cannabis-sector equity listed on OTCMKTS in the US MSO category. Use this profile to compare bullish and bearish opinions, monitor Form 4 insider buys and sells, and review the latest quarterly results.

CIN editorial stance: Neutral / Wait. Mixed data profile. Risk factors: insider selling. (2 bullish signals, 1 bearish signal.)

California-focused cultivator and retailer operating one of the largest greenhouses in North America.

Historical Price Data

5-year weekly price history, intraday quotes, and 52-week range for GLASF are maintained by Cannabis Investor News and refreshed throughout the trading day.